134 related articles for article (PubMed ID: 7547503)
21. Down-regulation of TSC-22 (transforming growth factor beta-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo.
Nakashiro K; Kawamata H; Hino S; Uchida D; Miwa Y; Hamano H; Omotehara F; Yoshida H; Sato M
Cancer Res; 1998 Feb; 58(3):549-55. PubMed ID: 9458104
[TBL] [Abstract][Full Text] [Related]
22. Angiogenesis by fibroblast growth factor 4 is mediated through an autocrine up-regulation of vascular endothelial growth factor expression.
Deroanne CF; Hajitou A; Calberg-Bacq CM; Nusgens BV; Lapière CM
Cancer Res; 1997 Dec; 57(24):5590-7. PubMed ID: 9407972
[TBL] [Abstract][Full Text] [Related]
23. Isolation of a novel oncogene, NET1, from neuroepithelioma cells by expression cDNA cloning.
Chan AM; Takai S; Yamada K; Miki T
Oncogene; 1996 Mar; 12(6):1259-66. PubMed ID: 8649828
[TBL] [Abstract][Full Text] [Related]
24. Modulation of cell growth and transformation by doxycycline-regulated FGF-2 expression in NIH-3T3 cells.
Gualandris A; Arese M; Shen B; Rifkin DB
J Cell Physiol; 1999 Nov; 181(2):273-84. PubMed ID: 10497306
[TBL] [Abstract][Full Text] [Related]
25. [Overexpression of EDAG-1 in NIH3T3 cells leads to malignant transformation].
Lü J; Xu WX; Wang SY; Jiang Y; Li CY; Cai WM; Yang XM
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Jan; 34(1):95-8. PubMed ID: 11958143
[TBL] [Abstract][Full Text] [Related]
26. The proto-oncogene FGF-3 is constitutively expressed in tumorigenic, but not in non-tumorigenic, clones of a human colon carcinoma cell line.
Galdemard C; Brison O; Lavialle C
Oncogene; 1995 Jun; 10(12):2331-42. PubMed ID: 7784081
[TBL] [Abstract][Full Text] [Related]
27. Characterization of Wnt-1 and Wnt-2 induced growth alterations and signaling pathways in NIH3T3 fibroblasts.
Bafico A; Gazit A; Wu-Morgan SS; Yaniv A; Aaronson SA
Oncogene; 1998 May; 16(21):2819-25. PubMed ID: 9652750
[TBL] [Abstract][Full Text] [Related]
28. [Molecular mechanism of androgen-dependent transformation--analysis using serum-free culture system].
Koga M; Kouhara H; Sato B
Hum Cell; 1993 Sep; 6(3):176-81. PubMed ID: 8297813
[TBL] [Abstract][Full Text] [Related]
29. High frequency of fibroblast growth factor (FGF) 8 expression in clinical prostate cancers and breast tissues, immunohistochemically demonstrated by a newly established neutralizing monoclonal antibody against FGF 8.
Tanaka A; Furuya A; Yamasaki M; Hanai N; Kuriki K; Kamiakito T; Kobayashi Y; Yoshida H; Koike M; Fukayama M
Cancer Res; 1998 May; 58(10):2053-6. PubMed ID: 9605740
[TBL] [Abstract][Full Text] [Related]
30. A novel recombinant basic fibroblast growth factor and its secretion.
Sohn YD; Lim HJ; Hwang KC; Kwon JH; Park HY; Chung KH; Cho SY; Jang Y
Biochem Biophys Res Commun; 2001 Jun; 284(4):931-6. PubMed ID: 11409882
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of the Na(+)/K(+)/Cl(-) cotransporter gene induces cell proliferation and phenotypic transformation in mouse fibroblasts.
Panet R; Marcus M; Atlan H
J Cell Physiol; 2000 Jan; 182(1):109-18. PubMed ID: 10567922
[TBL] [Abstract][Full Text] [Related]
32. Mouse fibroblast growth factor 10: cDNA cloning, protein characterization, and regulation of mRNA expression.
Beer HD; Florence C; Dammeier J; McGuire L; Werner S; Duan DR
Oncogene; 1997 Oct; 15(18):2211-8. PubMed ID: 9393979
[TBL] [Abstract][Full Text] [Related]
33. H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblasts.
Cuadrado A; Bruder JT; Heidaran MA; App H; Rapp UR; Aaronson SA
Oncogene; 1993 Sep; 8(9):2443-8. PubMed ID: 8361757
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
Michieli P; Li W; Lorenzi MV; Miki T; Zakut R; Givol D; Pierce JH
Oncogene; 1996 Feb; 12(4):775-84. PubMed ID: 8632899
[TBL] [Abstract][Full Text] [Related]
35. FGF-2 and FGF-1 expressed in rat bladder carcinoma cells have similar angiogenic potential but different tumorigenic properties in vivo.
Jouanneau J; Plouet J; Moens G; Thiery JP
Oncogene; 1997 Feb; 14(6):671-6. PubMed ID: 9038374
[TBL] [Abstract][Full Text] [Related]
36. The human FGF-8 gene localizes on chromosome 10q24 and is subjected to induction by androgen in breast cancer cells.
Payson RA; Wu J; Liu Y; Chiu IM
Oncogene; 1996 Jul; 13(1):47-53. PubMed ID: 8700553
[TBL] [Abstract][Full Text] [Related]
37. Wnt-10b directs hypermorphic development and transformation in mammary glands of male and female mice.
Lane TF; Leder P
Oncogene; 1997 Oct; 15(18):2133-44. PubMed ID: 9393971
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of human FGF8 activity by antisense constructs in murine fibroblastic and human prostatic carcinoma cell systems.
Rudra-Ganguly N; Zheng J; Hoang AT; Roy-Burman P
Oncogene; 1998 Mar; 16(11):1487-92. PubMed ID: 9525747
[TBL] [Abstract][Full Text] [Related]
39. The FGF-4 promoter is required for transformation and is active in both embryonal and somatic cells.
Lucas JM; Bryans M; Lo K; Wilkie NM; Freshney M; Thornton D; Lang JC
Oncol Res; 1994; 6(3):139-49. PubMed ID: 7994085
[TBL] [Abstract][Full Text] [Related]
40. Effect of overexpressing fibroblast growth factor 2 protein isoforms in osteoblastic ROS 17/2.8 cells.
Xiao L; Liu P; Sobue T; Lichtler A; Coffin JD; Hurley MM
J Cell Biochem; 2003 Aug; 89(6):1291-301. PubMed ID: 12898525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
